Prospidelong
Sector: Pharmaceuticals
Price: Contract Price
Minimum Order: 0,4 kg per year
Packaging: Glass jars of dark glass of 0.1 kg
Terms of Delivery: Transportation - in accordance with GOST 17768-90.
Storage - in a place protected from moisture and light at a temperature not exceeding +25 ° С.
New Message
Full Product Information:
"Prospidelong" antitumor substance is intended for the preparation of the medicine Prospidelong for the treatment of patients with gastric cancer with disseminated lesions of the peritoneum with the active substance prospidia chloride. Technical characteristics - In accordance with the draft FSP RB "Prospidelong, a substance, 100 g in banks." Analogues of the preparation for composition and use are absent. 2 patents of the Republic of Bashkortostan and 2 Russian patents on the preparation scheme and antitumor activity of a hydrogel preparation based on dextran phosphate with immobilized propidium chloride were obtained: 1. The patent of the Russian Federation 2442586, МПК А 61К 33/24. A 61K 47/38 / Hydrogel antitumor preparation TL. Yurkshtovich, A.A. Kladiev, N.V. Golub, P.M. Bychkovsky, V.A. Alinovskaya, R.I. Kosterova, S.A. Belyaev, S.A. Red, E.N. Alexandrova; the applicant is the Research Institute of FHP of BSU, Limited Liability Company "Biological Company of TNK", No. 2010134398/15; 11.11.2002., publ. 20.02.2012. 2. The patent of the Russian Federation 2455007, МПК А 61К31/721/The method of obtaining gels-forming phosphates of dextran TL. Yurkshtovich, S.A. Belyaev, N.K. Yurkshtovich, P.M. Bychkovsky, N.V. Golub, V.A. Alinovskaya, R.I. Kosterov; the applicant is the Research Institute of FHP of BSU, the State Scientific Institution "The Institute of General and Inorganic Chemistry of the National Academy of Sciences of Belarus". No. a. 2010144469; claimed. 01.11.2010, publ. 10.07.2012 3. Patent BY 15136, IPC C 08B 37/02, A 61P 35/00 / Method for obtaining the hydrogel of dextran phosphate TL Yurkshtovich, S.A. Belyaev, N.K. Yurkshtovich, P.M. Bychkovsky, N.V. Golub, V.A. Alinovskaya, R.I. Kosterov; applicant Institute of FHP BSU, State Scientific Institution "Institute of General and Inorganic Chemistry of the National Academy of Sciences of Belarus", No. 20091589; claimed. 11.11.2009, publ. 30.06.2011. 4. Patent BY 16349, IPC C08B 37/02, A 61R 35/00 / Gel-forming mixed phosphoric acid and carbamate esters of dextran, a method for their production T.L. Yurkshtovich, N.V. Golub, N.K. Yurkshtovich, R.I. Kosterova, VA, Alinovskaya, P.M. Bychkovsky, S.A. Belyaev; Applicant, Institute of General and Inorganic Chemistry of the National Academy of Sciences of Belarus, No. 2010134398/15; 11.11.2009, publ. 20.02.2012. Certificate of state registration "Unitehprom BSU" No. 190007888. Special permission (License) for pharmaceutical activities of the Ministry of Health of the Republic of Belarus №02040/882 of 25.03.2015.
Another products from the category "Pharmaceuticals"
Belarus
Hamoven is an original medicinal product, solution for infusions belonging to blood substitutes and protein fraction of blood plasma.
Belarus
Plasma substituting and perfusion solutions. Electrolyte solution. 9 mg/ml isotonic infusion solution of sodium chloride is colourless transparent liquid. The solution is produced sterile and non-pyro...